All In Biotech

Drug Trial Radar · NCT04542057

A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Last checked: Nov 20, 2026Latest source record: Oct 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 790 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

790

Actual

Start

Sep 22, 2020

Primary completion

May 3, 2022

Study completion Jul 6, 2022

Sponsor

Sponsor type
Industry
Collaborators
IQVIA Pty Ltd
First posted
Sep 9, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if ensifentrine is safe and effective for the treatment of patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

Conditions

  • Chronic Obstructive Pulmonary Disease

Interventions

  • EnsifentrineDrug

    Dosage Formulation: Ensifentrine Nebulizer suspension Dosage 3mg Frequency: Twice Daily for 24 weeks

  • PlaceboDrug

    Dosage Formulation: Ensifentrine Placebo Nebulizer solution Frequency: Twice Daily for 24 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Least Square (LS) Mean Change From Baseline in Average Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve Over 12 Hours (AUC0-12h) at Week 12Time frame: Baseline (40 minutes before first administration on Day 1) and Week 12

Locations

130 sites in 10 countries. Site status is shown where the registry gives one.

  • Wright Clinical Research, LLC

    Alabaster, Alabama

  • SEC Clinical Research

    Andalusia, Alabama

  • Jasper Summit Research LLC

    Jasper, Alabama

  • Pulmonary Associates Clinical Trials

    Phoenix, Arizona

  • Elite Clinical Studies LLC

    Phoenix, Arizona

  • Clinical Research Institute of Arizona, LLC

    Sun City West, Arizona

  • Premier Medical Group

    Bakersfield, California

  • Antelope Valley Clinical Trials

    Lancaster, California

  • Downtown LA Research Center, Inc.

    Los Angeles, California

  • UCLA Medical Center

    Los Angeles, California

  • California Medical Research Associates

    Northridge, California

  • Center for Clinical Trials of Sacramento, Inc.

    Sacramento, California

  • Integrated Research Center

    San Diego, California

  • Institute of HealthCare Assessment, Inc.

    San Diego, California

  • Alpine Clinical Research Center

    Boulder, Colorado

  • Innovative Research of West Florida

    Clearwater, Florida

  • Clinical Research of West Florida, Inc.

    Clearwater, Florida

  • Accel Research Sites - DeLand Clinical Research Unit

    DeLand, Florida

  • Riverside Clinical Research

    Edgewater, Florida

  • Medical Research of Central Florida

    Leesburg, Florida

  • Axcess Medical Research

    Loxahatchee Groves, Florida

  • Research Institute of South Florida

    Miami, Florida

  • Advanced Medical Research Institute

    Miami, Florida

  • Clinical Trials of Florida. LLC

    Miami, Florida

  • South Medical Research Group, Inc.

    Miami, Florida

  • ProCare Clinical Research

    Miami Gardens, Florida

  • HMD Research, LLC

    Orlando, Florida

  • Florida Institute for Clinical Research

    Orlando, Florida

  • Sarasota Clinical Research

    Sarasota, Florida

  • Coastal Pulmonary Critical Care

    St. Petersburg, Florida

  • Pasadena Center for Medical Research, LLC

    St. Petersburg, Florida

  • Clinical Research of West Florida, Inc.

    Tampa, Florida

  • Clinical Research Trials of Florida, Inc.

    Tampa, Florida

  • Florida Pulmonary Research Institute, LLC

    Winter Park, Florida

  • AMR New Orleans

    New Orleans, Louisiana

  • Genesis Clin RES& Consulting

    Fall River, Massachusetts

  • Minnesota Lung Center

    Edina, Minnesota

  • Minnesota Lung Center

    Woodbury, Minnesota

  • Midwest Chest Consultants

    Saint Charles, Missouri

  • Montana Medical Research Inc.

    Missoula, Montana

Showing 40 of 130 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.